EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sea Conch Peptides Hydrolysate Alleviates DSS-Induced Colitis in Mice through Immune Modulation and Gut Microbiota Restoration

Hidayat Ullah, Ting Deng, Muhsin Ali, Nabeel Ahmed Farooqui iD, Duaa M Alsholi iD, Nimra Zafar Siddiqui, Ata Ur Rehman, Sharafat Ali, Muhammad Ilyas, Liang Wang iD, Yi Xin iD

Molecules · 28.09.2023 · 28 (19) · 6849

DOI: 10.3390/molecules28196849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 28.09.2023. Verfasst von Hidayat Ullah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science. China, National Nature Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a persistent, lifelong inflammation of the digestive system. Dextran sulfate sodium is commonly used to induce colitis in experimental animal models, which causes epithelial damage, intestinal inflammation, mucin depletion, and dysbiosis of the gut microbiota. Various prebiotics, polysaccharides, and polypeptides are used for IBD treatment. In this study, we used a murine model utilizing BALB/c mice, with 10 mice per group, to investigate the treatment effect of sea conch peptide hydrolysate (CPH) on DSS-induced colitis mice. Colitis was induced through the administration of 2.5% DSS in drinking water over a seven-days period. Furthermore, on the eighth day of the experiment, sea conch peptide hydrolysate (CPH) at low (100 mg/kg), medium (200 mg/kg), and high (400 mg/kg) doses, which were continued for 14 days, were assessed for medicinal purposes in DSS-induced colitis mice. Our results showed that CPH treatment significantly alleviated the severity and symptoms of colitis. The epithelial integrity and histological damage were improved. Intestinal inflammation and inflammatory cell infiltration were improved. Furthermore, the expression of pro-inflammatory cytokines was reduced, and intestinal barrier integrity was restored by elevating the tight junction proteins. Moreover, 16s RNA sequencing revealed dysbiosis of the gut microbiota was observed upon DSS treatment, which was reinstated after CPH treatment. An increased level of Firmicutes and Lactobacillus was observed in the treatment groups. Finally, our results suggest that CPH would be recommended as a functional food source and also have the potential to be used as a medicinal product for different gastrointestinal disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitisInflammatory Bowel DiseasesMiceAnimalsDysbiosisCytokinesInflammationDextran SulfateMice, Inbred C57BLDisease Models, AnimalColon

Stichwörter der Autor:innen

dextran sulfate sodiumgut microbiotainflammatory bowel diseaseintestinal inflammationpeptides

Substanzen

CytokinesDextran Sulfate

Autor:innen und Institutionen

  • Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
  • Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
  • Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

ORCID-Profile: Nabeel Ahmed Farooqui, Duaa M Alsholi, Liang Wang, Yi Xin

Förderung

  • National Nature Science. China
  • National Nature Science Foundation of China

Zitieren

APA

Ullah, H., Deng, T., Ali, M., Farooqui, N. A., Alsholi, D. M., Siddiqui, N. Z., Rehman, A. U., Ali, S., Ilyas, M., Wang, L., & Xin, Y. (2023). Sea Conch Peptides Hydrolysate Alleviates DSS-Induced Colitis in Mice through Immune Modulation and Gut Microbiota Restoration. Molecules, 28(19), 6849. https://doi.org/10.3390/molecules28196849

Vancouver

Ullah H, Deng T, Ali M, Farooqui NA, Alsholi DM, Siddiqui NZ, et al. Sea Conch Peptides Hydrolysate Alleviates DSS-Induced Colitis in Mice through Immune Modulation and Gut Microbiota Restoration. Molecules. 2023;28(19):6849. doi:10.3390/molecules28196849

BibTeX
@article{Ullah2023,
  author = {Ullah, Hidayat and Deng, Ting and Ali, Muhsin and Farooqui, Nabeel Ahmed and Alsholi, Duaa M and Siddiqui, Nimra Zafar and Rehman, Ata Ur and Ali, Sharafat and Ilyas, Muhammad and Wang, Liang and Xin, Yi},
  title = {Sea Conch Peptides Hydrolysate Alleviates DSS-Induced Colitis in Mice through Immune Modulation and Gut Microbiota Restoration},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {19},
  pages = {6849},
  doi = {10.3390/molecules28196849}
}
Kostenlos starten →